论文信息 - Short communication Pulmonary resection for lung cancer in HIV-positive patients with low (B 200 lymphocytes:mm 3 ) CD4 count

Short communication Pulmonary resection for lung cancer in HIV-positive patients with low (B 200 lymphocytes:mm 3 ) CD4 count

The clinical improvement obtained with combination treatment has modified the therapeutic approach of lung cancer in HIV-positive patients. Aggressive surgical treatment has become a viable option for those patients in whom the CD4 cell count was greater than 200 lymphocytes:mm 3 . We recently extended our surgical indications to include two HIV-positive patients with lung cancer (stage IIIA and IIB) and low (B 200 lymphocytes:mm 3 ) CD4 count. Both patients underwent a lobectomy and mediastinal nodal dissection. The postoperative course was uneventful. No evidence of recurrent cancer was seen at 12 and 20 months after the operation. Based on this limited experience, we conclude that a low CD4 count should not represent, per se, an exclusion criterion for the surgical treatment of pleuropulmonary conditions in HIV-positive patients. © 2000 Elsevier Science Ireland Ltd. All rights reserved.

[1] J. Kaldor,et al. Risk of cancer in people with AIDS. , 1999, AIDS.

[2] F. Peyrade,et al. [Cancer in patients infected with the human immunodeficiency virus. The unusual aspects]. , 1999, Presse medicale.

[3] F. Dabis,et al. Rapid Change in the Use of Antiretroviral Agents and Improvement in a Population of HIV-Infected Patients: France, 1995 to 1997 , 1998 .

[4] E. Sandström,et al. Induction of specific T‐cell responses in HIV infection , 1998, AIDS.

[5] J. Jacobs,et al. Surgical treatment of lung cancer in patients with human immunodeficiency virus. , 1995, The Annals of thoracic surgery.

[6] M. Riquet,et al. Surgical management of thoracic manifestations in human immunodeficiency virus‐positive patients: Indications and results , 1995, The British journal of surgery.